How Should the Impact of Different Presentations of Treatment Effects on Patient Choice Be Evaluated? A Pilot Randomized Trial (original) (raw)

The Effect of Alternative Summary Statistics for Communicating Risk Reduction on Decisions About Taking Statins: A Randomized Trial

Shaun Treweek

PLoS …, 2009

View PDFchevron_right

The Statin Choice decision aid in primary care: A randomized trial

Victor M Montori

Patient Education and Counseling, 2010

View PDFchevron_right

Observational data for comparative effectiveness research: An emulation of randomised trials of statins and primary prevention of coronary heart disease

Luis Rodríguez

Statistical Methods in Medical Research, 2013

View PDFchevron_right

Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins

Mohammad Tavakkoli

American Journal of Epidemiology, 2012

View PDFchevron_right

“Clinician’s Use of the Statin Choice Decision Aid in Patients with Diabetes: a Videographic Study Nested in a Randomized Trial.”

Victor M Montori, Roberto Abadie

View PDFchevron_right

The effect of qualitative vs. quantitative presentation of probability estimates on patient decision-making: a randomized trial

Jennifer Biggs

Health Expectations, 2002

View PDFchevron_right

The Effect of How Outcomes Are Framed on Decisions about Whether to Take Antihypertensive Medication: A Randomized Trial

Doris Kristoffersen, Victor M Montori

PLoS ONE, 2010

View PDFchevron_right

Patients’ self-estimated likelihood of taking a statin as prescribed after different types of prognostic information

Stefan Agewall

Atherosclerosis, 2010

View PDFchevron_right

Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others

Lisa Bero

PLoS Medicine, 2007

View PDFchevron_right

Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice

A. Edwards, Dorte Jarbøl

BMC Health Services Research, 2013

View PDFchevron_right

Communicating clinical trial outcomes: Effects of presentation method on physicians’ evaluations of new treatments

Jonathan Rolison

View PDFchevron_right

Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice

Dorte Jarbøl

British Journal of General Practice, 2014

View PDFchevron_right

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

Hamid Reza Baradaran

BMC Medical Informatics and Decision Making

View PDFchevron_right

Benefit–risk assessment of HMG-CoA reductase inhibitors (statins): a discrete choice experiment

Korn Sornlertlumvanich

BMJ Open

View PDFchevron_right

How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease

Uffe Ravnskov

Expert review of clinical pharmacology, 2015

View PDFchevron_right

Should Statin Therapy Be Allocated on the Basis of Global Risk or on the Basis of Randomized Trial Evidence?

Steven Jones

The American Journal of Cardiology, 2010

View PDFchevron_right

Statistical issues in randomised controlled trials: a narrative synthesis

B. Egbewale

Asian Pacific Journal of Tropical Biomedicine, 2015

View PDFchevron_right

Use of Meta-analytic Results to Facilitate Shared Decision Making

Daniel Cher

Journal of the American Medical Informatics Association, 1999

View PDFchevron_right

Risk communication in clinical trials: A cognitive experiment and a survey

Cynthia Goh

BMC Medical Informatics and Decision Making, 2010

View PDFchevron_right

The Changing Face of Clinical Trials Evidence for Health Decision Making — Beyond Randomized, Controlled Trials

Maestría Ciencias Médicas

View PDFchevron_right

Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care

Emily Herrett

BMJ open, 2017

View PDFchevron_right

Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication—a sub-study of the VIPVIZA RCT

Ulf Näslund

European journal of clinical pharmacology, 2024

View PDFchevron_right

Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs

Peter Knapp

BMJ open, 2016

View PDFchevron_right

Identifying patient preferences for communicating risk estimates: a descriptive pilot study

Nananda Col

BMC medical informatics and decision making, 2001

View PDFchevron_right

Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatment

Felicitas Kuehne

Journal of Comparative Effectiveness Research, 2019

View PDFchevron_right

Patients Prefer Pictures to Numbers to Express Cardiovascular Benefit From Treatment

Sue Wells

The Annals of Family Medicine, 2008

View PDFchevron_right

Misperception among physicians and patients regarding the risks and benefits of statin treatment: the potential role of direct-to-consumer advertising

Phil Mendys

Journal of Clinical Lipidology, 2008

View PDFchevron_right